A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions

Phase 3 Unknown 346 enrolled Axsome Therapeutics, Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled, 24-week study to evaluate the efficacy and safety of AXS-02 in subjects with knee osteoarthritis associated with bone marrow lesions.

Timeline

Start: 2016-03
Primary completion: 2020-12
Completion: 2020-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AXS-02	Unknown	—	Oral

A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions

Summary

Timeline

Drugs

Indications